BACKGROUND: Coronary spasm seems to be associated with coronary nitric oxide deficiency. OBJECTIVES: We investigated whether the Glu298Asp polymorphism in the endothelial nitric oxide synthase (eNOS) gene is a definite risk factor for coronary spasm and whether diffuse spasm involving normal-looking coronary artery correlates significantly with the Glu298Asp polymorphism, in contrast with focal spasm superimposed on an atherosclerotic plaque. METHODS: A polymerase chain reaction followed by restriction fragment length polymorphism analysis was performed in 118 control participants and in 102 patients with variant angina and a similar degree of atherosclerotic burden. Patients with coronary spasm were divided into diffuse spasm and focal spasm subgroups according to morphological criteria. RESULTS: There was a significantly higher incidence of the Glu298Asp polymorphism in the coronary spasm group than in the control group (21.5% compared with 8.5%, P=0.006). Multiple logistic regression analysis using risk factors and the Glu298Asp polymorphism showed that the most important predictive factor for coronary spasm was the Glu298Asp polymorphism (odds ratio 2.83, 95% confidence interval 1.25-6.41, P=0.009). The diffuse spasm subgroup had a significantly higher frequency of the Glu298Asp polymorphism than the control group (25.9% compared with 8.5%, P=0.002). However, the focal spasm subgroup did not differ from the control group in the frequency of Glu298Asp polymorphism. CONCLUSION: The Glu298Asp polymorphism in the eNOS gene is a definite risk factor for coronary spasm, especially for diffuse coronary spasm. This result supports the notion that diffuse coronary spasm is significantly associated with endothelial dysfunction, in contrast to focal spasm.
BACKGROUND:Coronary spasm seems to be associated with coronary nitric oxide deficiency. OBJECTIVES: We investigated whether the Glu298Asp polymorphism in the endothelial nitric oxide synthase (eNOS) gene is a definite risk factor for coronary spasm and whether diffuse spasm involving normal-looking coronary artery correlates significantly with the Glu298Asp polymorphism, in contrast with focal spasm superimposed on an atherosclerotic plaque. METHODS: A polymerase chain reaction followed by restriction fragment length polymorphism analysis was performed in 118 control participants and in 102 patients with variant angina and a similar degree of atherosclerotic burden. Patients with coronary spasm were divided into diffuse spasm and focal spasm subgroups according to morphological criteria. RESULTS: There was a significantly higher incidence of the Glu298Asp polymorphism in the coronary spasm group than in the control group (21.5% compared with 8.5%, P=0.006). Multiple logistic regression analysis using risk factors and the Glu298Asp polymorphism showed that the most important predictive factor for coronary spasm was the Glu298Asp polymorphism (odds ratio 2.83, 95% confidence interval 1.25-6.41, P=0.009). The diffuse spasm subgroup had a significantly higher frequency of the Glu298Asp polymorphism than the control group (25.9% compared with 8.5%, P=0.002). However, the focal spasm subgroup did not differ from the control group in the frequency of Glu298Asp polymorphism. CONCLUSION: The Glu298Asp polymorphism in the eNOS gene is a definite risk factor for coronary spasm, especially for diffuse coronary spasm. This result supports the notion that diffuse coronary spasm is significantly associated with endothelial dysfunction, in contrast to focal spasm.
Authors: Mohamed Z Gad; Mohamed F Abdel Rahman; Ingy M Hashad; Sahar M Abdel-Maksoud; Nabil M Farag; Khaled Abou-Aisha Journal: Genet Test Mol Biomarkers Date: 2012-06-25
Authors: Nerissa U Ko; Pam Rajendran; Helen Kim; Martin Rutkowski; Ludmila Pawlikowska; Pui-Yan Kwok; Randall T Higashida; Michael T Lawton; Wade S Smith; Jonathan G Zaroff; William L Young Journal: Stroke Date: 2008-02-28 Impact factor: 7.914
Authors: Xue Zhang; Amy I Lynch; Barry R Davis; Charles E Ford; Eric Boerwinkle; John H Eckfeldt; Catherine Leiendecker-Foster; Donna K Arnett Journal: PLoS One Date: 2012-03-28 Impact factor: 3.240
Authors: Suk Min Seo; Yoon Seok Koh; Hae Ok Jung; Jin Soo Choi; Pum Joon Kim; Sang Hong Baek; Ho-Joong Youn; Kweon-Haeng Lee; Ki-Bae Seung Journal: Korean Circ J Date: 2011-07-30 Impact factor: 3.243
Authors: George K Andrikopoulos; Dimitris K Grammatopoulos; Stylianos E Tzeis; Sevasti I Zervou; Dimitris J Richter; Michalis N Zairis; Elias J Gialafos; Dimitris C Sakellariou; Stefanos G Foussas; Antonis S Manolis; Christodoulos I Stefanadis; Pavlos K Toutouzas; Edward W Hillhouse Journal: BMC Med Genet Date: 2008-05-21 Impact factor: 2.103